UBS Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329M | Sell |
|
|||||
|
2025
Q1 | $407M | Sell |
|
|||||
|
2024
Q4 | $408M | Buy |
|
|||||
|
2024
Q3 | $426M | Buy |
|
|||||
|
2024
Q2 | $392M | Sell |
|
|||||
|
2024
Q1 | $380M | Buy |
|
|||||
|
2023
Q4 | $278M | Buy |
|
|||||
|
2023
Q3 | $217M | Sell |
|
|||||
|
2023
Q2 | $292M | Buy |
|
|||||
|
2023
Q1 | $227M | Sell |
|
|||||
|
2022
Q4 | $318M | Buy |
|
|||||
|
2022
Q3 | $198M | Sell |
|
|||||
|
2022
Q2 | $227M | Buy |
|
|||||
|
2022
Q1 | $196M | Sell |
|
|||||
|
2021
Q4 | $188M | Sell |
|
|||||
|
2021
Q3 | $181M | Buy |
|
|||||
|
2021
Q2 | $177M | Sell |
|
|||||
|
2021
Q1 | $167M | Sell |
|
|||||
|
2020
Q4 | $154M | Sell |
|
|||||
|
2020
Q3 | $138M | Buy |
|
|||||
|
2020
Q2 | $95.2M | Sell |
|
|||||
|
2020
Q1 | $84.6M | Sell |
|
|||||
|
2019
Q4 | $122M | Sell |
|
|||||
|
2019
Q3 | $99M | Sell |
|
|||||
|
2019
Q2 | $120M | Buy |
|
|||||
|
2019
Q1 | $117M | Buy |
|
|||||
|
2018
Q4 | $98.1M | Sell |
|
|||||
|
2018
Q3 | $112M | Sell |
|
|||||
|
2018
Q2 | $106M | Buy |
|
|||||
|
2018
Q1 | $83.2M | Sell |
|
|||||
|
2017
Q4 | $126M | Buy |
|
|||||
|
2017
Q3 | $73.5M | Sell |
|
|||||
|
2017
Q2 | $75.4M | Buy |
|
|||||
|
2017
Q1 | $63.2M | Buy |
|
|||||
|
2016
Q4 | $54M | Buy |
|
|||||
|
2016
Q3 | $44.2M | Buy |
|
|||||
|
2016
Q2 | $23M | Sell |
|
|||||
|
2016
Q1 | $25.6M | Sell |
|
|||||
|
2015
Q4 | $33.2M | Sell |
|
|||||
|
2015
Q3 | $36.7M | Sell |
|
|||||
|
2015
Q2 | $45M | Sell |
|
|||||
|
2015
Q1 | $48.4M | Buy |
|
|||||
|
2014
Q4 | $30.9M | Buy |
|